Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients

Abstract

Introduction: Pseudomonas aeruginosa infections are prevalent amongst chronic rhinosinusitis (CRS) sufferers. Many P. aeruginosa strains form biofilms, leading to treatment failure. Lytic bacteriophages (phages) are viruses that infect, replicate within, and lyse bacteria, causing bacterial death.Aim: To assess the activity of a phage cocktail in eradicating biofilms of ex vivo P.aeruginosa isolates from CRS patients.Methods: P. aeruginosa isolates from CRS patients with and without cystic fibrosis (CF) across three continents were multi-locus sequence typed and tested for antibiotic resistance. Biofilms grown in vitro were treated with a cocktail of four phages (CT-PA). Biofilm biomass was measured after 24 and 48 h, using a crystal violet assay. Phage titrations were performed to confirm replication of the phages. A linear mixed effects model was applied to assess the effects of treatment, time, CF status, and multidrug resistance on the biomass of the biofilm.Results: The isolates included 44 strain types. CT-PA treatment significantly reduced biofilm biomass at both 24 and 48 h post-treatment (p < 0.0001), regardless of CF status or antibiotic resistance. Biomass was decreased by a median of 76% at 48 h. Decrease in biofilm was accompanied by a rise in phage titres for all except one strain.Conclusion: A single dose of phages is able to significantly reduce biofilms formed in vitro by a range of P.aeruginosa isolates from CRS patients. This represents an exciting potential and novel targeted treatment for P. aeruginosa biofilm infections and multidrug resistant bacteria.

Bacteriophages inhibit biofilms formed by multi-drug resistant bacteria isolated from septic wounds

“…Methanol was removed, and each well was added 200 μL of crystal violet (1% v/v, Qualigens, Mumbai) and incubated for 15 min. The absorbance of eluted stain was measured at 570 nm in a spectrophotometer (Bio-Rad Laboratories, Hercules, CA, USA), and triplicates were maintained (Pires et al, 2011; Coulter et al, 2014; Fong et al, 2017).…”

Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection

“…Bacteriophages live in dynamic relationships with bacteria and have coevolved over time. Given this coevolution, bacteriophages have developed innate ability penetrate biofilms and lyse bacteria inside biofilms [4][5][6]. Bacteriophages also have the ability to disrupt the biofilm's extracellular matrix with the use of depolymerase enzymes [4][5][6].…”

“…Given this coevolution, bacteriophages have developed innate ability penetrate biofilms and lyse bacteria inside biofilms [4][5][6]. Bacteriophages also have the ability to disrupt the biofilm's extracellular matrix with the use of depolymerase enzymes [4][5][6]. It is therefore postulated that bacteriophages may be promising agents Antibiotics 2020, 9, 241 2 of 6 to help cure clinical biofilm infections.…”

Novel nitric oxide‒generating platform using manuka honey as an anti‐biofilm strategy in chronic rhinosinusitis

“…Antibiotic sensitivities were determined using a VITEK 2 system (bioMérieux, Durham, NC). A biofilm‐forming reference strain of PA, obtained from the American Type Culture Collection (ATCC 15692), and previously used by other investigators to evaluate anti‐biofilm therapeutics, was used in this study …”

“…A biofilm-forming reference strain of PA, obtained from the American Type Culture Collection (ATCC 15692), and previously used by other investigators to evaluate anti-biofilm therapeutics, was used in this study. 19 Fabrication of NO-releasing particles SNO-MP was synthesized as described elsewhere. 17 In brief, an organosilica sol-gel monolith was formed containing many covalently attached nitrosated thiol groups.…”